Clinical Trial Update: A Novel Treatment For Chronic Posttraumatic Stress Disorder (PTSD) Using Post-Reactivation Propranolol [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial is evaluating post-reactivation propranolol as a treatment for chronic post-traumatic stress disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Douglas Mental Health University Institute | Conditions: Stress Disorders, Post-Traumatic | Phase 2, Phase 3 | Status: UNKNOWN